No matter your situation, we are here to provide personalized support and effective treatment options to help you succeed on your weight loss journey!
Schedule a consultation today, and let’s determine the best weight loss solution for you.







Ozempic®, Wegovy® Zepbound®, and Mounjaro® are GLP-1 medications that has drastically change how a person loose weight. According to clinical trials, average weight loss while on GLP-1/GIP (tirzepatide) medications such as Zepbound® and Mounjaro® has shown over 14% weight loss over a period of 72 weeks (Tirzepatide studies). Additional studies for GLP-1 (semaglutide) medications such as Wegovy® and Ozempic ® have shown a weight loss of approximately 14.9% over a period of 68 weeks (Semaglutide studies).
For medications like Wegovy® (Semaglutide) or Zepbound® (Tirzepatide), our medical team will submit prior authorization to your insurance to determine eligibility.
Send prescription for Zepbound vials or Wegovy pens for cash pay directly to Lilly Direct® Pharmacy or NovoCare® pharmacy.
Pay using FSA/HSA and we can take care of any letter of medical necessity paperwork needed.
No personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia, Type II (MEN II)
BMI of 30+ kg/m², or BMI of 27–29.9 kg/m² with an obesity-related condition
Zepbound is FDA approved for both obstructive sleep apnea or obesity
Wegovy is FDA approved to treat patients with established cardiovascular disease and either obesity or overweight or to reduce ones body weight in adults and pediatric patients aged 12 years and older.












Recent blood work (within the last year), including: CMP, Lipid Panel, TSH, A1C
If you meet these criteria, our team will handle the insurance process to maximize your coverage and help you begin your weight loss journey with the most effective treatment options available.
To start your weight loss journey with Wegovy®, Zepbound®, Ozempic®, or Mounjaro® just follow these three easy steps:

Take the first step toward achieving your weight loss goals today!
Please be aware that insurance approval is not guaranteed, and we cannot ensure that the approved medication will be available at a specific cost or in stock at your local pharmacy. Availability and pricing are determined by your insurance provider and pharmacy supply.
Weight loss management with GLP-1 medications such as semaglutide and GLP-1/GIP medications such as tirzepatide from one of our compound pharmacies may be an option for you!
We offer Personalized Compound GLP-1 and GLP-1/GIP injections. Includes provider review, medication, supplies, initial order of zofran and annual labs at Quest
Tailored to meet your specific weight loss goals.
Adjusted dosing to improve adherence and minimize side effects such as nausea, stomach discomfort, and lean muscle loss.
For patients who prefer to avoid weekly injections while still benefiting from GLP-1 therapy.
While compounded medications are not FDA-approved, our Semaglutide and Tirzepatide formulations are sourced from FDA-inspected, state-regulated pharmacies that meet strict safety and quality standards.
Unlike brand-name medications, compounded Semaglutide and Tirzepatide are cash-pay only and not covered by insurance.
Traditional dosing and formulation of semaglutide and tirzepatide cannot be compounded unless commercially available semaglutide and tirzepatide medications are on the FDA shortage list.
Need help deciding what medication is best for you? Let’s get you scheduled for a free virtual visit with our weight loss consultants or following the 3 steps listed below. Some states require an initial video consultation.
Choose your medication option
If approved, medication gets shipped directly to your home in 7-10 days.
When you’re ready for a refill, simply submit a request using our Refill Request Form.
Compounded medications are not FDA-approved but are sourced from FDA-inspected, state-regulated pharmacies.
While compounded Semaglutide & Tirzepatide offer a great alternative, availability is subject to supply shortages.

**Wegovy®, Victoza®, Ozempic®, and Saxenda® are registered trademarks of Novo Nordisk. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Labanks Medical is not affiliated with Novo Nordisk or Eli Lilly, and the compound products offered by Labanks Medical Services are not produced by these companies or our company. Compound medications may be prescribed when appropriate based on the patient’s medical needs. While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review.
Copyright © 2025 LaBanks Medical, All Rights Reserved.
Complete the form below and someone will be in touch, to schedule an initial appointment!

Thank you for your submission. We have received your information and will process it shortly. You will receive a confirmation email within the next few minuets.